Actinium Pharmaceuticals
ATNM
#9726
Rank
A$53.35 M
Marketcap
$1.71
Share price
-7.83%
Change (1 day)
-85.83%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -A$66.68 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.08 Million. In 2023 the company made an earning of -A$83.77 Million a decrease over its 2022 earnings that were of -A$55.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$66.68 Million-20.4%
2023 -A$83.77 Million52.24%
2022 -A$55.03 Million36.61%
2021 -A$40.28 Million11.48%
2020 -A$36.13 Million1.46%
2019 -A$35.61 Million-7.37%
2018 -A$38.45 Million-11.46%
2017 -A$43.42 Million10.67%
2016 -A$39.24 Million15.7%
2015 -A$33.91 Million-14.86%
2014 -A$39.83 Million129.19%
2013 -A$17.38 Million-8.55%
2012 -A$19.01 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.05 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$60.01 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.63 B-970.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$46.4 Million-36.04%๐Ÿ‡บ๐Ÿ‡ธ USA